CompsDesk

ACADIA PHARMACEUTICALS INC (ACAD) — benchmarks from SEC filings

Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%

$1.07BRevenue FY2025
11.9%Revenue growth
9.8%Operating margin
36.5%Net margin
9.8%FCF margin
Fiscal yearRevenueOp marginNet margin
FY2025$1.07B9.8%36.5%
FY2024$958M24.1%23.6%
FY2023$726M-10.1%-8.4%
FY2022$517M-43.2%-41.8%
FY2021$484M-35.2%-34.7%

How does ACAD compare against its actual peer set?

The full CompsDesk Peer Benchmark Pack: 13 metrics × 5 years × your chosen peers, percentile placement, provenance for every number, board-ready PDF. One-off $249 — see a free sample pack first.

Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.